Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.
D000224:Addison Disease / Q000276:immunology; D000293:Adolescent; D000302:Adrenal Cortex / Q000276:immunology; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D000918:Antibody Specificity; D001323:Autoantibodies / Q000302:isolation & purification*; D001327:Autoimmune Diseases / Q000150:complications; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology*; D004700:Endocrine System Diseases / Q000276:immunology*; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000302:isolation & purification; D007328:Insulin / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000276:immunology; D010179:Pancreas / Q000473:pathology; D013270:Stomach / Q000276:immunology; D013961:Thyroid Gland / Q000276:immunology; D013966:Thyroiditis / Q000276:immunology
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D007074:Immunoglobulin G; D007328:Insulin